Physician profile
Daniel E Westerdahl
NPI 1396061834
$11,224.55
in general payments reported to CMS, 2019-2025
15 companies · $1,456 in 2025
The $1,456 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,808 · 2020: $203 · 2021: $4,157 · 2022: $1,146 · 2023: $1,075 · 2024: $1,380 · 2025: $1,456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,746 · Travel and Lodging: $165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,745.67 |
| Travel and Lodging | $164.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,417.76 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Amplatzer Talisman, Epic |
| Ancora Heart, INC. | $1,765.88 | 2022-2025 | Accucinch |
| Medtronic Vascular, INC. | $1,191.90 | 2019-2020 | |
| Abiomed | $770.89 | 2019-2025 | Impella |
| Boehringer Ingelheim Pharmaceuticals, INC. | $265.53 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $207.28 | 2022-2023 | |
| Paragonix Technologies, INC. | $160.04 | 2024 | |
| Pfizer INC. | $121.36 | 2019 | |
| Cardiac Dimensions, INC. | $61.49 | 2024-2025 | |
| Alnylam Pharmaceuticals INC. | $56.13 | 2025 | Amvuttra |
| Medtronic, INC. | $56.00 | 2021-2023 | Hvad Pump Implant Kit |
| Impulse Dynamics (USA) INC. | $47.23 | 2024 | Optimizer |
| Novartis Pharmaceuticals Corporation | $43.36 | 2019-2023 | |
| Nuwellis, INC. | $32.58 | 2020 | |
| Cvrx, INC. | $27.12 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Westerdahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.